DK3714070T3 - Hidtil ukendt cip2a-variant og anvendelser deraf - Google Patents
Hidtil ukendt cip2a-variant og anvendelser deraf Download PDFInfo
- Publication number
- DK3714070T3 DK3714070T3 DK18811327.8T DK18811327T DK3714070T3 DK 3714070 T3 DK3714070 T3 DK 3714070T3 DK 18811327 T DK18811327 T DK 18811327T DK 3714070 T3 DK3714070 T3 DK 3714070T3
- Authority
- DK
- Denmark
- Prior art keywords
- cip2a
- variant
- hitherto unknown
- hitherto
- unknown
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20176032 | 2017-11-20 | ||
PCT/FI2018/050844 WO2019097122A1 (en) | 2017-11-20 | 2018-11-20 | A novel cip2a variant and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3714070T3 true DK3714070T3 (da) | 2022-02-07 |
Family
ID=64556938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK18811327.8T DK3714070T3 (da) | 2017-11-20 | 2018-11-20 | Hidtil ukendt cip2a-variant og anvendelser deraf |
Country Status (7)
Country | Link |
---|---|
US (1) | US11680092B2 (da) |
EP (1) | EP3714070B1 (da) |
JP (1) | JP7150018B2 (da) |
CA (1) | CA3082650A1 (da) |
DK (1) | DK3714070T3 (da) |
ES (1) | ES2906203T3 (da) |
WO (1) | WO2019097122A1 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020212650A1 (en) * | 2019-04-18 | 2020-10-22 | Turun Yliopisto | Method for predicting response to treatment with tyrosine kinase inhibitors and related methods |
JP7450249B2 (ja) | 2020-03-04 | 2024-03-15 | 国立大学法人山口大学 | 修飾蛋白質の生産装置及び生産方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6743619B1 (en) * | 2001-01-30 | 2004-06-01 | Nuvelo | Nucleic acids and polypeptides |
US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
EP2021499A4 (en) * | 2005-12-16 | 2010-02-17 | Univ Leland Stanford Junior | FUNCTIONAL ARRAYS FOR THE IDENTIFICATION OF ELEMENTS FOR GENE PRESSION REGULATION WITH HIGH THROUGHPUT |
US20090007281A1 (en) * | 2006-01-13 | 2009-01-01 | Battelle Memorial Institute | Animal Model for Assessing Copd-Related Diseases |
FI20060246A0 (fi) * | 2006-03-16 | 2006-03-16 | Jukka Westermarck | Uusi kasvua stimuloiva proteiini ja sen käyttö |
US8900813B2 (en) * | 2010-08-17 | 2014-12-02 | Medical Diagnostic Laboratories, Llc | CIP2A as a biomarker in detection of cervical cancer |
US20130115599A1 (en) * | 2011-11-08 | 2013-05-09 | Medical Diagnostic Laboratories, Llc | Increased cip2a expression and bladder cancer in humans |
-
2018
- 2018-11-20 JP JP2020527797A patent/JP7150018B2/ja active Active
- 2018-11-20 WO PCT/FI2018/050844 patent/WO2019097122A1/en active Search and Examination
- 2018-11-20 CA CA3082650A patent/CA3082650A1/en active Pending
- 2018-11-20 ES ES18811327T patent/ES2906203T3/es active Active
- 2018-11-20 DK DK18811327.8T patent/DK3714070T3/da active
- 2018-11-20 EP EP18811327.8A patent/EP3714070B1/en active Active
- 2018-11-20 US US16/765,084 patent/US11680092B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2021503289A (ja) | 2021-02-12 |
WO2019097122A1 (en) | 2019-05-23 |
US20200354434A1 (en) | 2020-11-12 |
EP3714070B1 (en) | 2021-12-29 |
JP7150018B2 (ja) | 2022-10-07 |
CA3082650A1 (en) | 2019-05-23 |
ES2906203T3 (es) | 2022-04-13 |
US11680092B2 (en) | 2023-06-20 |
EP3714070A1 (en) | 2020-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3383916T3 (da) | Anti-CD73-antistoffer og anvendelser deraf | |
DK3448386T3 (da) | Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf | |
DK3452463T3 (da) | Amidsubstituerede pyridinyltriazolderivater og anvendelser deraf | |
DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
DK3365368T3 (da) | Tgfbeta1-bindende immunoglobuliner og anvendelse deraf | |
DK3268470T3 (da) | Transposasepolypeptider og anvendelser deraf | |
DK3157552T3 (da) | Syntac-polypeptider og anvendelser deraf | |
DK3532499T3 (da) | ANTI-IL-33-antistoffer og anvendelser deraf | |
DK3692015T3 (da) | Hidtil ukendte glutaminantagonister og anvendelser deraf | |
DK3484865T3 (da) | Somatostatinmodulatorer og anvendelser deraf | |
DK3668512T3 (da) | Pyruvatkinasemodulatorer og anvendelse deraf | |
DK3402821T3 (da) | Psma-bindende antistof og anvendelser deraf | |
DK3543240T3 (da) | URAT1-inhibitor og anvendelse deraf | |
DK3430129T3 (da) | Kolonidannende medium og anvendelse deraf | |
DK3621694T3 (da) | Lrrc33-inhibitorer og anvendelse heraf | |
DK3612579T3 (da) | Pultrudat, fremstilling og anvendelse heraf | |
DK3233105T3 (da) | Hidtil ukendt kombination og anvendelse | |
DK3448419T3 (da) | Interferon-beta-antistoffer og anvendelser deraf | |
DK3516160T3 (da) | Brøndanordning og tilhørende fremgangsmåder | |
DK3417058T3 (da) | Sortase-modificerede molekyler og anvendelser deraf | |
MA49905A (fr) | Polyesteramines et polyesterquats | |
DK3128005T3 (da) | Sirp-alfa-variantkonstruktioner og anvendelser deraf | |
DK3672948T3 (da) | Pyridinamin-pyridon- og pyrimidinamin-pyridonforbindelser | |
DK3490988T3 (da) | Ny forbindelse og fremgangsmåde | |
DK3474883T3 (da) | Komplementinhibitorer og anvendelser deraf |